Issuer · CIK 0001367644

EBS — Emergent BioSolutions Inc.

Recent filings

Mar 5, 2026·Form 4·Other$199.6K
EBS/Emergent BioSolutions Inc.
LINDAHL RICHARD S · EVP, Chief Financial Officer
scoring

← Back to all filings

EBS (Emergent BioSolutions Inc.) — recent insider filings — Form 4 AI